• 1
    Khatcheressian JL, Wolff AC, Smith TJ et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J. Clin. Oncol. 2006; 24: 50915097.
  • 2
    National Health and Medical Research Council. Clinical Practice Guidelines for the Management of Early Breast Cancer – Second Edition. 2001. [Cited 27 Aug 2012.] Available from URL:
  • 3
    Grunfeld E, Noorani H, McGahan L et al. Surveillance mammography after treatment of primary breast cancer: a systematic review. Breast 2002; 11: 228235.
  • 4
    The GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators. JAMA 1994; 271: 15871592.
  • 5
    Kokko R, Hakama M, Holli K. Role of chest X-ray in diagnosis of the first breast cancer relapse: a randomized trial. Breast Cancer Res. Treat. 2003; 81: 3339.
  • 6
    Mehta VK, Goffinet DR. Unsuspected abnormalities noted on CT treatment-planning scans obtained for breast and chest wall irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2001; 49: 723725.
  • 7
    Drotman MB, Machnicki SC, Schwartz LH, Winston CB, Yoo HH, Panicek DM. Breast cancer: assessing the use of routine pelvic CT in patient evaluation. AJR Am. J. Roentgenol. 2001; 176: 14331436.
  • 8
    Tomin R, Donegan WL. Screening for recurrent breast cancer – its effectiveness and prognostic value. J. Clin. Oncol. 1987; 5: 6267.
  • 9
    Gorechlad JW, McCabe EB, Higgins JH et al. Screening for recurrences in patients treated with breast-conserving surgery: is there a role for MRI? Ann. Surg. Oncol. 2008; 15: 17031709.
  • 10
    Isasi CR, Moadel RM, Blaufox MD. A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res. Treat. 2005; 90: 105112.
  • 11
    Lijovic M, Davis SR, Fradkin P et al. Use of a cancer registry is preferable to a direct-to-community approach for recruitment to a cohort study of wellbeing in women newly diagnosed with invasive breast cancer. BMC Cancer 2008; 8: 126.
  • 12
    Lijovic M, Davis SR, Fradkin P et al. The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancer. Fam. Cancer 2009; 8: 299305.
  • 13
    Sobin LH , Wittekind C (eds). Classification of Malignant Tumours, 6th edn. New York: Wiley-Liss, 2002.
  • 14
    Berg WA, Blume JD, Cormack JB et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 2008; 299: 21512163.
  • 15
    Dent SF, Gaspo R, Kissner M, Pritchard KI. Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer. Breast Cancer Res. Treat. 2011; 126: 295310.
  • 16
    Robertson C, Arcot Ragupathy SK, Boachie C et al. The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation. Health Technol. Assess. 2011; 15: vvi, 1–322.
  • 17
    National Cancer Institute, US National Institutes of Health. Cancer Trends Progress Report – 2009/2010 update. 2010. [Cited 27 Aug 2012.] Available from URL:
  • 18
    Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, Brown ML. Evaluation of trends in the cost of initial cancer treatment. J. Natl. Cancer Inst. 2008; 100: 888897.
  • 19
    Schapira DV, Urban N. A minimalist policy for breast cancer surveillance. JAMA 1991; 265: 380382.
  • 20
    Mille D, Roy T, Carrere MO et al. Economic impact of harmonizing medical practices: compliance with clinical practice guidelines in the follow-up of breast cancer in a French Comprehensive Cancer Center. J. Clin. Oncol. 2000; 18: 17181724.
  • 21
    Smith TJ, Hillner BE. Bending the cost curve in cancer care. N. Engl. J. Med. 2011; 364: 20602065.